The drug for secretolytic therapy in acute and chronic bronchopulmonary diseases
Adults and children over 2 years old
Ambroxol-Vishpha - a drug for secretolytic therapy
01.About the drug
The drug for secretolytic therapy in acute and chronic bronchopulmonary diseases associated with impaired bronchial secretion and mucus movement. Available in the form of syrup, 15 mg/5 ml in a 100 ml bottle.
See package insert for more details.
Select country of instruction: